Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet

Epileptic Disorders

Volumn 14, Issue 4, 2012, Pages 438-441

  Martikainen, Mika H ^a   Päivärinta, Markku ^a   Jääskeläinen, Satu ^a   Majamaa, Kari ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Epilepsy; Ketogenic diet; Low glycemic index treatment; Mitochondrial disease; POLG

Indexed keywords

ANALGESIC AGENT; DNA DIRECTED DNA POLYMERASE GAMMA; ETIRACETAM; OXCARBAZEPINE; PHENYTOIN; SERINE; TRYPTOPHAN;

ADULT; APHASIA; BLURRED VISION; CASE REPORT; DNA DIRECTED DNA POLYMERASE GAMMA RELATED MITOCHONDRIAL EPILEPSY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC STATE; FEMALE; FLUSHING; GENE MUTATION; GLYCEMIC INDEX; HEADACHE; HOMONYMOUS HEMIANOPIA; HUMAN; KETOGENIC DIET; NUCLEAR MAGNETIC RESONANCE IMAGING; POLG1 GENE; PRIORITY JOURNAL; REVIEW; SPEECH DISORDER; TONIC CLONIC SEIZURE;

ANTICONVULSANTS; DNA-DIRECTED DNA POLYMERASE; EPILEPSY; FEMALE; GLYCEMIC INDEX; HUMANS; KETOGENIC DIET; MITOCHONDRIAL DISEASES; PIRACETAM; YOUNG ADULT;

EID: 84874587368     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2012.0543     Document Type: Review

References (10)

1. Ahola-Erkkilä S, Carroll CJ, Peltola-Mjösund K, et al. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet 2010;19:1974-84.
2. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007;48:43-58.
3. Hakonen AH, Heiskanen S, Juvonen V, et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005;77:430-41.
4. Joshi CN, Greenberg CR, Mhanni AA, Salman MS. Ketogenic diet in Alpers-Huttenlocher syndrome. Pediatr Neurol 2009;40:314-6.
5. Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 2012;25:173-8.
6. Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005;65:1810-2.
7. Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical disease caused by the A467T and W748S POLGmutations: a study of 26 cases. Brain 2006;129:1685-92.
8. Uusimaa J, Hinttala R, Rantala H, et al. Homozygous W748S mutation in the POLG1 gene in patients with juvenileonset Alpers syndrome and status epilepticus. Epilepsia 2008;49:1038-45.
9. Visser NA, Braun KP, Leijten FS, et al. Magnesium treatment for patients with refractory status epilepticus due to POLG1 mutations. J Neurol 2011;258:218-22.
10. Wolf NI, Rahman S, Schmitt B, et al. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009;50:1596-607.